颈动脉粥样硬化斑块稳定性评估正电子发射断层扫描/磁共振研究进展

doi:10.3969/j.issn.1006-7795.2021.01.006

摘要/Abstract

摘要： 颈动脉粥样硬化斑块破裂是导致脑梗死的主要原因,探索斑块进展的病理生理机制,尽早发现易损斑块是国际研究热点。研究显示炎性反应与斑块发生、发展、破裂密切相关,但炎性反应过程及其与预后关系的病理生理机制尚不清楚。高分辨磁共振成像(high-resolution magnetic resonance imaging,HR-MRI)和正电子发射断层扫描(positron emission tomography,PET)是评价颈动脉粥样硬化斑块的有力手段,HR-MRI能提供斑块形态学信息,PET能提供斑块内炎性反应的巨噬细胞代谢信息。本文重点对HR-MRI、PET及一体化PET/MR成像在颈动脉粥样硬化斑块稳定性评估的研究进展进行综述,阐明颈动脉斑块易损性的病理生理机制,以期进行早期影像学预警,有效预防脑梗死。

关键词: 动脉粥样硬化, 颈动脉斑块, 高分辨磁共振成像, 正电子发射断层扫描, 一体化PET/MR

Abstract: Rupture of carotid atherosclerotic plaque is the primary cause of cerebral infarction. It is a cutting edge in atherosclerosis to investigate the pathophysiological mechanism of vulnerable plaque progression for early detection. Recent studies have revealed that inflammation may cause the occurrence, development, and rupture of atherosclerotic plaque, however, its physiological mechanism and relationship with the outcome of atherosclerotic plaque are poorly understood. High-resolution magnetic resonance imaging(HR-MRI)and positron emission tomography(PET)are the non-invasive imaging technology and increasingly applied to evaluate atherosclerotic plaque. As HR-MRI is used for imaging morphology of carotid plaque with high spatial resolution, PET can be used for quantitative imaging macrophages metabolism of response to inflammation with high sensitivity and specificity. In this work, we reviewed the research progresses in the evaluation of carotid atherosclerotic plaque stability with HR-MRI, PET and simultaneous PET/MR imaging to reveal the physiological mechanism of inflammation and plaque stability and provide early imaging warning of vulnerable plaques, and develop more effective treatment strategies. It may play an important role in effectively preventing the occurrence of cerebral infarction.

Key words: atherosclerosis, carotid plaque, high-resolution magnetic resonance imaging(HR-MRI), positron emission tomography(PET), simultaneous PET/MR

中图分类号:

R445

张越, 卢洁. 颈动脉粥样硬化斑块稳定性评估正电子发射断层扫描/磁共振研究进展[J]. 首都医科大学学报, 2021, 42(1): 31-36.

Zhang Yue, Lu Jie. Research progresses in evaluating the stability of carotid atherosclerotic plaque with positron emission tomography/computed tomography[J]. Journal of Capital Medical University, 2021, 42(1): 31-36.

参考文献

[1] GBD 2016 Stroke Collaborators.Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the global burden of disease study 2016 [J].Lancet Neurol, 2019, 18(5):459-480.
[2] Feigin V L, Forouzanfar M H, Krishnamurthi R, et al.Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 [J].Lancet, 2014, 383 (9913):245-254.
[3] Saba L, Saam T, Jäger H R, et al.Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications [J].Lancet Neurol, 2019, 18(6):559-572.
[4] Liu L, Wang D, Wong K S, et al.Stroke and stroke care in China: huge burden, significant workload,and a national priority [J].Stroke, 2011, 42(12): 3651-3654.
[5] Ibrahimi P, Jashari F, Nicoll R, et al.Coronary and carotid atherosclerosis: how useful is the imaging [J].Atherosclerosis, 2013, 231(2):323-333.
[6] Millon A, Mathevet J L, Boussel L, et al.High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques [J].J Vasc Surg, 2013, 57(4):1046-1051.
[7] Grimm J M, Schindler A, Freilinger T, et al.Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR [J].J Cardiovasc Magn Reson, 2013, 15(1):44.
[8] Yamada K, Kawasaki M, Yoshimura S, et al.High-intensity signal in carotid plaque on routine 3D-TOF-MRA is a risk factor of ischemic stroke [J].Cerebrovasc Dis, 2016, 41(1-2):13-18.
[9] Saba L, Yuan C, Hatsukami T S, et al.Carotid artery wall imaging perspective and guidelines from the ASNR vessel wall imaging study group and expert consensus recommendations of the American society of neuroradiology [J].AJNR Am J Neuroradiol, 2018, 39(2): E9-E31.
[10]Müller H F, Viaccoz A, Fisch L, et al.¹⁸FDG-PET-CT: an imaging biomarker of high-risk carotid plaques.Correlation to symptoms and microembolic signals [J].Stroke, 2014, 45(12):3561-3566.
[11]Ali A, Tawakol A.FDG PET/CT Imaging of Carotid Atherosclerosis [J].Neuroimaging Clin N Am, 2016, 26(1):45-54.
[12]Cai J, Hatsukami T S, Ferguson M S, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology [J].Circulation, 2005, 112(22):3437-3444.
[13]Touzé E, Toussaint J F, Coste J, et al.Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials [J].Stroke, 2007, 38(6):1812-1819.
[14]Xia Z, Yang H, Yuan X, et al. High-resolution magnetic resonance imaging of carotid atherosclerotic plaques-a correlation study with histopathology [J]. Vasa, 2017, 46(4):283-290.
[15]Selwaness M, Bos D, van den Bouwhuijsen Q, et al.Carotid atherosclerotic plaque characteristics on magnetic resonance imaging relate with history of stroke and coronary heart disease [J].Stroke, 2016, 47(6): 1542-1547.
[16]Sun J, Balu N, Hippe D S, et al.Subclinical carotid atherosclerosis: short term natural history of lipid-rich necrotic core-a multicenter study with MR imaging [J].Radiology, 2013, 268(1):61-68.
[17]Takaya N, Yuan C, Chu B, et al.Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study [J].Circulation, 2005, 111(21):2768- 2775.
[18]Kashiwazaki D, Akioka N, Kuwayama N, et al.Pathophysiology of acute cerebrovascular syndrome in patients with carotid artery stenosis: magnetic resonance imaging/single-photon emission computed tomography study [J].Neurosurgery, 2015, 76(4):427-433.
[19]Takaya N, Yuan C, Chu B, et al.Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results [J].Stroke, 2006, 37(3):818-823.
[20]Redgrave J N, Lovett J K, Gallagher P J, et al.Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study [J].Circulation, 2006, 113(19): 2320-2328.
[21]Wang J, Liu H, Sun J, et al.Varying correlation between ¹⁸F-fluorodeoxy glucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis implications for plaque inflammation [J].Stroke, 2014, 45(6):1842-1845.
[22]Wang X, Sun J, Zhao X, et al.Ipsilater plaques display higher T1 signals than contralateral plaques in recently symptomatic patients with bilateral carotid intraplaque hemorrhage [J].Atherosclerosis, 2017, 257:78-85.
[23]West A M, Anderson J D, Meyer C H, et al.The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline [J].Atherosclerosis, 2011, 218(1):156-162.
[24]Geovanini G R, Libby P.Atherosclerosis and inflammation: overview and updates [J].Clin Sci, 2018, 132(12): 1243-1252.
[25]Libby P. Inflammation in atherosclerosis [J].Arterioscler Thromb Vasc Biol,2012, 32(9):2045-2051.
[26]Tarkin J M, Joshi F R, Rudd J H.PET imaging of inflammation in atherosclerosis [J].Nat Rev Cardiol,2014, 11(8):443-457.
[27]Tawakol A, Fayad Z A, Mogg R, et al.Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxy glucose-positron emission tomography/computed tomography feasibility study [J].J Am Coll Cardiol, 2013, 62(10):909-917.
[28]Shaharuddin S, Azman A Z F, Ali K H, et al.Vulnerable plaque detection: the role of 18-fluorine fluorodeoxyglucose in identifying high risk patients [J].Alex J Med, 2013, 49:329-336.
[29]Marnane M, Merwick A, Sheehan O C, et al.Carotid plaque inflammation on ¹⁸F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence [J].Ann Neurol, 2012, 71(5):709- 718.
[30]Mateo J, Izquierdo-Garcia D, Badimon J J, et al.Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using¹⁸F- fluoromisonidazole positron emission tomographic imaging [J].Circ Cardiovasc Imaging, 2014, 7(2):312-320.
[31]Mechtouff L, Sigovan M, Douek P, et al.Simultaneous assessment of microcalcifications and morphological criteria of vulnerability in carotid artery plaque using hybrid F-NaF PET/MRI [J].J Nucl Cardiol, 2020, Online ahead of print.
[32]Derlin T, Wisotzki C, Richter U, et al.In vivo imaging of mineral deposition in carotid plaque using ¹⁸F-sodium fluoride PET/CT: correlation with atherogenic risk factors [J].J Nucl Med, 2011, 52(3):362-368.
[33]Vesey A T, Jenkins W S, Irkle A, et al.¹⁸F-fluoride and ¹⁸F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor ischemic stroke: case-control study [J].Circ Cardiovasc Imaging, 2017, 10(3):e004976.
[34]Cocker M S, Spence J D, Hammond R, et al.¹⁸F-NaF PET/CT identifies active calcification in carotid plaque [J].JACC Cardiovasc Imaging, 2016, 10(4): 486-488.
[35]Kircher M, Tran-Gia J, Kemmer L, et al.Imaging inflammation in atherosclerosis with CXCR4-directed ⁶⁸Ga-pentixafor PET/CT: correlation with ¹⁸F-FDG PET/CT [J].J Nucl Med, 2020, 61(5):751-756.
[36]Vesey A T, Dweck M R, Fayad Z A.Utility of combining PET and MR imaging of carotid plaque [J].Neuroimaging Clin N Am, 2016, 26 (1):55-68.
[37]Aizaz M, Moonen R P M, van der Pol J A J, et al.PET/MRI of atherosclerosis [J].Cardiovasc Diagn Ther, 2020, 104(4): 1120-1139.
[38]Evans N R, Tarkin J M, Le E P, et al.Integrated cardiovascular assessment of atherosclerosis using PET/MRI [J].Br J Radiol,2020, 93(1113):20190921.
[39]Li X, Heber D, Rausch I, et al.Quantitative assessment of atherosclerotic plaques on ¹⁸F-FDG PET/MRI: comparison with a PET/CT hybrid system [J].Eur J Nucl Med Mol Imaging, 2016, 43(8): 1503-1512.
[40]Ripa R S, Knudsen A, Hag A M, et al.Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT [J].Am J Nucl Med Mol Imaging, 2013, 3(4):361-371.
[41]Eldib M, Bini J, Lairez O, et al.Feasibility of ¹⁸F-fluorodeoxy glucose radiotracer dose reduction in simultaneous carotid PET/MR imaging [J].Am J Nucl Med Mol Imaging, 2015, 5(4):401-407.
[42]Rischpler C, Nekolla S G, Beer A J.PET/MR imaging of atherosclerosis: initial experience and outlook [J].Am J Nucl Med Mol Imaging, 2013, 3(5):393-396.
[43]Li X, Heber D, Leike T, et al.⁶⁸Ga-pentixafor PET/MRI for the detection of chemokine receptor 4 expression in atherosclerotic plaques [J].Eur J Nucl Med Mol Imaging, 2018, 45(4): 558-566.
[44]Li X, Yu W, Wollenweber T, et al.⁶⁸Ga-pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery [J].Eur J Nucl Med Mol Imaging, 2019, 46(8): 1616-1625.